A white-label telehealth platform should give you a UK-regulated clinical workflow, a GPhC-registered dispensing operation, a prescriber network, and the integrations you need for payments, identity, and support — all under your brand. Choosing the right one means looking at six things: regulatory posture, clinical model, dispensing scope, integrations, pricing structure, and exit terms. This piece walks through each so your shortlist actually compares like-for-like.
What 'white-label' actually means in UK telehealth
White-label means the platform provides the underlying regulated service — clinical workflow, prescribers, dispensing — under your brand. The patient-facing experience carries your name; the regulatory backbone is operated by the platform. The boundary varies by vendor: some white-label only the clinical layer, some include dispensing, some include support and integrations. Make sure you understand what your shortlisted vendor actually white-labels before signing.
Regulatory posture — GPhC, MHRA, CQC, ICO — verify all four
The platform's regulatory posture matters more than its marketing copy. GPhC-registered dispensing premises with a named superintendent pharmacist. MHRA compliance for medicines handling and Yellow Card reporting. CQC registration (or formal exemption documentation) for the clinical service. UK GDPR / DPA compliance with a DPA the platform will sign. If any of these are vague or 'in progress', ask hard questions before adding to the shortlist.
Clinical model — prescriber network, governance, escalation
Three questions for the clinical model. Does the platform supply the prescribers, or are you expected to bring them? What is the clinical governance framework — protocols, peer review, audit? How are clinical escalations handled, and what is the SLA? PExpo's brand model includes the prescriber network and clinical governance framework as standard — see our brand model page. Other platforms ask the brand to bring their own clinicians, which shifts the recruitment and credentialing burden to you.
Dispensing scope — same-day, cold-chain, controlled drugs
Not every white-label platform dispenses every category. Check: same-day dispatch on in-stock SKUs, cold-chain handling (GLP-1, biologics, HRT), controlled drug handling if you need it, and the SKU range available. A platform that does not handle cold-chain natively means you cannot launch a GLP-1 brand on it — at least not without extra integration work and unmanaged regulatory exposure.
Integrations — payments, identity, support, marketing
The integration scope determines what you have to build separately. Payments (Stripe, Adyen). Identity (Onfido, Veriff, Yoti). Support (Intercom, Zendesk). Marketing or CDP (Customer.io, Klaviyo). Pre-built integrations save you engineering time; missing integrations mean custom work. See our integrations page for what PExpo natively connects with.
Pricing structure — platform fees, per-dispense fees, exit terms
Pricing structures vary widely. Some platforms charge a monthly platform fee plus per-dispense. Some charge revenue share. Some charge a flat per-dispense and zero platform fee. PExpo's clinic model is £0 platform fees with a transparent per-request admin client care fee; the brand model is per-dispense configured per-category. Check exit and data-portability terms — what happens to your patients, records, and brand if you switch.
A platform that does not handle cold-chain natively means you cannot launch a GLP-1 brand on it. Check this before signing — it is the single most common gap in UK white-label platforms.
Make sure you understand what your shortlisted vendor actually white-labels before signing. The term covers a wide span of scope across vendors.
Choosing a white-label telehealth platform in the UK is a six-dimension comparison — regulatory posture, clinical model, dispensing scope, integrations, pricing structure, and exit terms. The platforms worth shortlisting are explicit on all six. The ones worth deprioritising are vague on any of them. See our brand model page for what PExpo's white-label includes specifically, our pricing page for the commercial structure, and our integrations page for the connected ecosystem.
Frequently asked questions
What does a white-label telehealth platform include?
Most include the clinical workflow (intake, consultation, prescribing) under your brand. Some also include the prescriber network, clinical governance, GPhC-compliant dispensing, and integrations with payments and identity. PExpo includes all of the above; some vendors only include the clinical workflow and expect you to bring your own clinicians and dispensing partner.
How is white-label different from licensing a SaaS telehealth platform?
White-label means the regulated services (prescribing, dispensing) are provided by the platform under your brand. Licensing a SaaS platform usually means you operate the regulated services yourself and the platform just provides software. White-label is faster to launch; SaaS gives more control.
Can I switch white-label platforms if my brand grows?
Depends on the platform's exit terms. Check data-portability and patient-records handover provisions before signing. PExpo's contracts are explicit on data return and continuity-of-care obligations — see our brand model page or DPA for detail.
Does PExpo handle GLP-1 dispensing on its white-label platform?
Yes — PExpo handles cold-chain dispensing for GLP-1 receptor agonists, biologics, and certain HRT formulations under UK GDP. See our brand model and integrations pages for the full operational scope.
